Skip to main content

Table 3 Characterization of PHBV-PTX-NPs, PDA-PHBV-PTX-NPs and RGD-PDA-PHBV-PTX-NPs

From: pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma

Samples (n = 3)

Size (nm)

PDI

LE (%)

EE (%)

PHBV-PTX-NPs

66.7 ± 5.2

0.142

21.48 ± 0.83

74.42 ± 1.21

PDA-PHBV-PTX-NPs

113.5 ± 7.4

0.153

15.33 ± 0.74

73.45 ± 1.03

RGD-PDA-PHBV-PTX-NPs

124.6 ± 7.7

0.163

14.21 ± 0.66

71.21 ± 1.06

  1. Data presents as mean ± standard deviation
  2. PDI polydispersion index, LE drug loading efficiency, EE encapsulation efficiency